Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Multiple sclerosis drug improves memory in mouse model of Alzheimer's disease

Multiple sclerosis drug improves memory in mouse model of Alzheimer's disease

New insight into how neurons and astrocytes work together to form healthy synapses

New insight into how neurons and astrocytes work together to form healthy synapses

'Switching on' Sight using Gene Therapy

'Switching on' Sight using Gene Therapy

Novel research reveals a vital but previously unknown role for microglia

Novel research reveals a vital but previously unknown role for microglia

Researchers map proteo-genomic connections between different human diseases

Researchers map proteo-genomic connections between different human diseases

Brain immune cells take up large amounts of sugar at the beginning of neurodegenerative disease

Brain immune cells take up large amounts of sugar at the beginning of neurodegenerative disease

Oral diuretic pill may potentially be repurposed to treat Alzheimer's in people with genetic risk

Oral diuretic pill may potentially be repurposed to treat Alzheimer's in people with genetic risk

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

Genome Research' special issue covers advanced developments in single-cell genomics

Genome Research' special issue covers advanced developments in single-cell genomics

Researchers identify host entry factor for Rift Valley fever virus

Researchers identify host entry factor for Rift Valley fever virus

Study explores the benefits of the MIND diet for older adults

Study explores the benefits of the MIND diet for older adults

Study uses mouse models to identify the likely cause of Alzheimer's disease

Study uses mouse models to identify the likely cause of Alzheimer's disease

Researchers develop novel cell reprogramming strategy to slow down glioblastomas

Researchers develop novel cell reprogramming strategy to slow down glioblastomas

Scientists use stem cells to investigate the genetic risk for Alzheimer's disease

Scientists use stem cells to investigate the genetic risk for Alzheimer's disease

NYU Tandon professors show broad therapeutic potential of novel peptide to combat multiple diseases

NYU Tandon professors show broad therapeutic potential of novel peptide to combat multiple diseases

Brain cholesterol promotes toxic amyloid plaque formation in Alzheimer’s disease

Brain cholesterol promotes toxic amyloid plaque formation in Alzheimer’s disease

New mouse line reveals the state of proteostasis in mammalian brain for the first time

New mouse line reveals the state of proteostasis in mammalian brain for the first time

Novel genome-editing technology to mitigate Alzheimer’s disease

Novel genome-editing technology to mitigate Alzheimer’s disease

Study reveals how 3D space is represented in the mammalian cortex by the brain's 'GPS'

Study reveals how 3D space is represented in the mammalian cortex by the brain's 'GPS'

Muscle protein tied to physical fitness in youth and age-associated diseases

Muscle protein tied to physical fitness in youth and age-associated diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.